[1]杨万秋,张旭东,张明智,等.成人散发性伯基特淋巴瘤/白血病临床分析[J].新乡医学院学报,2020,37(2):144-147.[doi:10.7683/xxyxyxb.2020.02.010]
　YANG Wanqiu,ZHANG Xudong,ZHANG Mingzhi,et al.Clinical analysis of adults patients with sporadic Burkitt lymphoma/leukemia[J].Journal of Xinxiang Medical University,2020,37(2):144-147.[doi:10.7683/xxyxyxb.2020.02.010]
点击复制

成人散发性伯基特淋巴瘤/白血病临床分析
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
37
期数:
2020年2
页码:
144-147
栏目:
临床研究
出版日期:
2020-02-05

文章信息/Info

Title:
Clinical analysis of adults patients with sporadic Burkitt lymphoma/leukemia
作者:
杨万秋1; 张旭东2; 张明智2; 陈清江1
（1.新乡医学院第三附属医院肿瘤科，河南　新乡　453003；2.郑州大学第一附属医院肿瘤科，河南　郑州　450003）
Author(s):
YANG Wanqiu1; ZHANG Xudong2; ZHANG Mingzhi2; CHEN Qingjiang1
（1.Department of Oncology，the Third Affiliated Hospital of Xinxiang Medical University，Xinxiang 453003，Henan Province，China；2.Department of Oncology，the First Affiliated Hospital of Zhengzhou University，Zhengzhou 450003，Henan Province，China）
关键词:
伯基特淋巴瘤/白血病; 成人; 11q异常; MYC基因易位
Keywords:
Burkitt lymphoma/leukemia; adult; 11q aberration; MYC gene translocation
分类号:
R781.6
DOI:
10.7683/xxyxyxb.2020.02.010
文献标志码:
A
摘要:
目的　探讨成人散发性伯基特淋巴瘤/白血病（BL）的临床特征、治疗方案，为临床治疗提供依据。方法　回顾性分析2013年6月至2019年6月郑州大学第一附属医院收治的31例成人BL患者的临床资料。结果　31例BL患者中，男18例，女13例，中位发病年龄30（16~65）岁；常见的侵犯部位为腹腔/盆腔器官20例（64.5%），颈部12例（38.7%），骨髓8例（25.8%）；EB病毒编码的小RNA阳性率为5/17（29.4%）；MYC基因易位阳性率为13/15（86.7%），2例MYC基因无易位患者中1例伴11q异常。患者平均生存时间（17.51±3.08）个月，1 a 总体生存率为60.1 %。单因素分析显示，年龄≥50岁、治疗未达完全缓解（CR）、β2微球蛋白升高可以降低患者的1 a总体生存率（P＜0.05）。结论　成人散发性BL易侵犯结外器官，患者生存期短，年龄≥50岁、治疗效果未达CR、血清β2微球蛋白水平升高是患者的不良预后因素。
Abstract:
Objective　To provide basis for clinical treatment of the patients with adult sporadic Burkitt lymphoma/leukemia (BL) by investigate the clinical characteristics and therapeutic regimens.Methods　The clinical data of 31 patients who were diagnosed BL in the First Affiliated Hospital of Zhengzhou University from June 2013 to June 2019 was statistically analyzed retrospectively.Results　Among the 31 BL patients,there were 18 males and 13 females,with the median age of onset being 30(range 16-65) years old.The common affected organs included abdominal/pelvic organs in 20 cases (64.5%),12 cases of neck (38.7%),8 cases of bone marrow (25.8%).The rate of overexpression of Epstein barr virus encoded RNA（EBER）was 5/17(29.4%) and MYC translocation was 13/15(86.7%) .Among the 2 patients without translocation of MYC gene,1 patient with 11q abnormal BL was found .The average survival time of the patients was （17.51±3.08） months,the 1-year overall survival rate was 60.1%.Univariate analysis results showed that patients with ≥50 years of age，the treatment effect did not achieved complete remission（CR）and elevated β2 microglobulin could reduce the 1-year overall survival rate of patients with BL (P<0.05).Conclusions　The patients with adult sporadic BL is prone to invade extraterritoral organs, and the survival time of the patients is short.Age ≥50 years old, treatment effect not achieve CR and serum levels of β2 microglobulin increasing were the poor prognostic factors of the patients.

参考文献/References:

［1］　吴艳林.儿童非霍奇金淋巴瘤61例临床特点和预后影响因素分析［J］.中华实用儿科临床杂志,2017,32(7):535-538.
［2］　KELLY J L,TOOTHAKER S R,CIMINELLO L,et al.Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensivechemotherapeutic regimens［J］.Clin Lymphoma Myeloma,2009,9(4):307-310.
［3］　JACOBSON C,LACASCE A.How I treat Burkitt lymphoma in adults［J］.Blood,2014,124(19):2913-2920.
［4］　王粹，徐笑笑，王振兴，等.成人散发性伯基特淋巴瘤的临床特点分析［J］.中华医学杂志,2014,94(2):148-150.
［5］　DUNLEAVY K,LITTLE R F,WILSON W H.Update on Burkitt Lymphoma［J］.Hematol Oncol Clin North Am,2016,30(6):1333-1343.
［6］　GASTWIRT J P,ROSCHEWSKI M.Management of adults with Burkitt lymphoma［J］.Clin Adv Hematol Oncol,2018,16(12):812-822.
［7］　RYMKIEWICZ G,GRYGALEWICZ B,CHECHLINSKA M,et al.A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-likelymphoma with 11q aberration［J］.Mod Pathol,2018,31(5):732-743.
［8］　LINCH D C.Burkitt lymphoma in adults［J］.Br J Haematol,2012,156(6):693-703.
［9］　DUNLEAVY K.Approach to the diagnosis and treatment of adult Burkitt′s lymphoma［J］.J Oncol Pract,2018,14(11):665-671.
［10］　PAINSCHAB M S,WESTMORELAND K D,KASONKANJI E,et al.Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi［J］.Blood Adv,2019,3(4):612-620.
［11］　SONG J Y,VENKATARAMAN G,FEDORIW Y,et al.Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults［J］.Leuk Lymphoma,2016,57(4):866-871.
［12］　KASAMON Y L,BRODSKY R A,BOROWITZ M J,et al.Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia［J］.Leuk Lymphoma,2013,54(3):483-490.
［13］　DUNLEAVY K,PITTALUGA S,SHOVLIN M,et al.Low-intensity therapy in adults with Burkitt′s lymphoma［J］.N Engl J Med,2013,369(20):1915-1925.
［14］　ALDERUCCIO J P,LOSSOS I S.DA-EPOCH-R for Adult Burkitt′s Lymphoma:Pros and Cons［J］.J Oncol Pract,2018,14(11):676-678.
［15］　WASTERLID T,BROWN P N,HAGBERG O,et al.Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma:a retrospectivepopulation-based study from the Nordic Lymphoma Group［J］.Ann Oncol,2013,24(7):1879-1886.
［16］　MIN H,YANG J,WANG S,et al.Remission of HIV-related na ve and high-risk Burkitt′s lymphoma treated by autologous stem celltransplantation plus cART［J］.Stem Cell Res Ther,2018,9(1):353-359.
［17］　KOJIMA M,NAKAMURA N,YABE M,et al.A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission［J］.Int J Hematol,2015,101(5):520-524.
［18］　RIBRAG V,KOSCIELNY S,BOSQ J,et al.Rituximab and dose-dense chemotherapy for adults with Burkitt′s lymphoma:a randomised,controlled,open-label,phase 3 trial［J］.Lancet,2016,387(10036):2402-2411.
［19］　HOELZER D,WALEWSKI J,DOHNER H,et al.Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy:reportof a large prospective multicenter trial［J］.Blood,2014,124(26):3870-3879.
［20］　RIZZIERI D A,JOHNSON J L,BYRD J C,et al.Improved efficacy using rituximab and brief duration,high intensity chemotherapy with filgrastimsupport for Burkitt or aggressive lymphomas:cancer and Leukemia Group B study ［J］.Br J Haematol,2014,165(1):102-111.

相似文献/References:

[1]殷国田,孙海燕,赵国安,等.成人心室肌致密化不全的临床特征[J].新乡医学院学报,2006,23(06):601.
[2]张志东,程兆云,权晓强,等.成人法洛氏四联征52 例外科治疗[J].新乡医学院学报,2006,23(05):520.

更新日期/Last Update: 2020-02-05